Ferroptosis Regulator Information
General Information of the Ferroptosis Regulator (ID: REG10042)
Full List of the Ferroptosis Target of This Regulator and Corresponding Disease/Drug Response(s)
KDM4A
can regulate the following target(s), and cause disease/drug response(s). You can browse detail information of target(s) or disease/drug response(s).
Browse Target
Browse Disease
Cystine/glutamate transporter (SLC7A11) [Driver; Suppressor]
In total 1 item(s) under this target | |||||
Experiment 1 Reporting the Ferroptosis Target of This Regulator | [1] | ||||
Target for Ferroptosis | Suppressor | ||||
Responsed Disease | Osteosarcoma | ICD-11: 2B51 | |||
Pathway Response | Fatty acid metabolism | hsa01212 | |||
Ferroptosis | hsa04216 | ||||
Cell Process | Cell ferroptosis | ||||
Cell metastasis | |||||
In Vitro Model |
143B cells | Osteosarcoma | Homo sapiens | CVCL_2270 | |
HOS cells | Osteosarcoma | Homo sapiens | CVCL_0312 | ||
In Vivo Model |
For the xenograft mouse model, 1 x 106 OS 143B cells in 100 uL PBS were subcutaneously injected with 1 x 106 OS cells. For the OS lung metastasis model and in vivo imaging, 1 x 106 143B cells in 10 uL PBS were injected orthotopically into the medullary cavity of the tibia of mice. For bioluminescent imaging, we used 143B cells stably expressing luciferase, and the luciferase substrate D-Luciferin (Selleck, China) was retro-orbitally injected before imaging on days 7 and 21.
Click to Show/Hide
|
||||
Response regulation | KDM4A regulates SLC7A11 transcription and osteosarcoma cell ferroptosis by controlling H3K9me3 demethylation in the promoter region of SLC7A11. The findings suggestes that KDM4A activity may be a potential therapeutic target for future OS treatment. | ||||
Osteosarcoma [ICD-11: 2B51]
In total 1 item(s) under this disease | |||||
Experiment 1 Reporting the Ferroptosis-centered Disease Response | [1] | ||||
Target Regulator | Lysine-specific demethylase 4A (KDM4A) | Protein coding | |||
Pathway Response | Fatty acid metabolism | hsa01212 | |||
Ferroptosis | hsa04216 | ||||
Cell Process | Cell ferroptosis | ||||
Cell metastasis | |||||
In Vitro Model |
143B cells | Osteosarcoma | Homo sapiens | CVCL_2270 | |
HOS cells | Osteosarcoma | Homo sapiens | CVCL_0312 | ||
In Vivo Model |
For the xenograft mouse model, 1 x 106 OS 143B cells in 100 uL PBS were subcutaneously injected with 1 x 106 OS cells. For the OS lung metastasis model and in vivo imaging, 1 x 106 143B cells in 10 uL PBS were injected orthotopically into the medullary cavity of the tibia of mice. For bioluminescent imaging, we used 143B cells stably expressing luciferase, and the luciferase substrate D-Luciferin (Selleck, China) was retro-orbitally injected before imaging on days 7 and 21.
Click to Show/Hide
|
||||
Response regulation | KDM4A regulates SLC7A11 transcription and osteosarcoma cell ferroptosis by controlling H3K9me3 demethylation in the promoter region of SLC7A11. The findings suggestes that KDM4A activity may be a potential therapeutic target for future OS treatment. | ||||